Wells Fargo & Company Alector, Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Alector, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 37,966 shares of ALEC stock, worth $62,264. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,966
Previous 25,313 49.99%
Holding current value
$62,264
Previous $118,000 39.83%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$1.72 - $6.06 $21,763 - $76,677
12,653 Added 49.99%
37,966 $71,000
Q3 2024

Nov 13, 2024
SELL
$4.34 - $6.58 $3,389 - $5,138
-781 Reduced 2.99%
25,313 $118,000
Q2 2024

Aug 13, 2024
BUY
$4.19 - $6.23 $17,660 - $26,259
4,215 Added 19.27%
26,094 $118,000
Q1 2024

May 10, 2024
BUY
$5.69 - $8.08 $29,508 - $41,902
5,186 Added 31.07%
21,879 $131,000
Q4 2023

Feb 09, 2024
SELL
$3.77 - $8.39 $113,789 - $253,235
-30,183 Reduced 64.39%
16,693 $133,000
Q3 2023

Nov 13, 2023
SELL
$5.2 - $8.77 $43,175 - $72,817
-8,303 Reduced 15.05%
46,876 $303,000
Q2 2023

Aug 15, 2023
BUY
$5.86 - $7.93 $10,969 - $14,844
1,872 Added 3.51%
55,179 $331,000
Q1 2023

May 12, 2023
BUY
$5.85 - $9.84 $311,834 - $524,521
53,305 Added 2665250.0%
53,307 $329,000
Q4 2022

Feb 13, 2023
SELL
$6.88 - $9.55 $25,339 - $35,172
-3,683 Reduced 99.95%
2 $0
Q3 2022

Nov 14, 2022
SELL
$8.19 - $13.2 $27,854 - $44,893
-3,401 Reduced 48.0%
3,685 $35,000
Q2 2022

Aug 12, 2022
SELL
$7.65 - $14.24 $458,617 - $853,688
-59,950 Reduced 89.43%
7,086 $73,000
Q1 2022

May 16, 2022
SELL
$13.02 - $20.78 $231,677 - $369,759
-17,794 Reduced 20.98%
67,036 $955,000
Q4 2021

Feb 14, 2022
BUY
$19.35 - $25.54 $803,160 - $1.06 Million
41,507 Added 95.81%
84,830 $1.75 Million
Q3 2021

Nov 15, 2021
BUY
$21.65 - $39.49 $874,789 - $1.6 Million
40,406 Added 1385.19%
43,323 $989,000
Q2 2021

Aug 16, 2021
SELL
$15.5 - $22.48 $44,051 - $63,888
-2,842 Reduced 49.35%
2,917 $60,000
Q1 2021

May 13, 2021
SELL
$14.84 - $22.23 $1.11 Million - $1.67 Million
-74,932 Reduced 92.86%
5,759 $116,000
Q4 2020

Feb 09, 2021
BUY
$9.4 - $16.7 $572,563 - $1.02 Million
60,911 Added 307.94%
80,691 $1.22 Million
Q3 2020

Nov 05, 2020
SELL
$10.54 - $24.96 $43,730 - $103,559
-4,149 Reduced 17.34%
19,780 $209,000
Q2 2020

Aug 13, 2020
SELL
$21.87 - $33.11 $775,641 - $1.17 Million
-35,466 Reduced 59.71%
23,929 $585,000
Q1 2020

May 14, 2020
BUY
$16.25 - $35.28 $965,168 - $2.1 Million
59,395 New
59,395 $1.43 Million

Others Institutions Holding ALEC

# of Institutions
155
Shares Held
55M
Call Options Held
39.7K
Put Options Held
51K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $135M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email